CNS Pharmaceuticals (CNSP) Reports Q4 Loss of $0.17/sh
Tweet
Share
E-mailGet Alerts CNSP Hot Sheet
Join SI Premium – FREE
CNS Pharmaceuticals (NASDAQ: CNSP) reported Q4 EPS of ($0.17), versus ($0.63) reported last year.
For earnings history and earnings-related data on CNS Pharmaceuticals (CNSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
